UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 30, 2024 4:00 P.M.

Form:	S-3
CIK: 0001672619 Company Name: Enliven Therapeutics, Inc. File Number: 333-278801